NCT06317168

Brief Summary

This study aims to assess whether removing single elements of the standardized office BP measurement procedure will affect the accuracy towards the mean awake ambulatory BP. Four arms are planned in a randomized order: 1) full standardized procedure, 2) standardized procedure but with cuff placed on a sleeve, 3) standardized procedure but arm resting vertically, 4) standardized procedure but with non-validated device. This is a pilot study to inform on the sample size required to perform adequately powered large scale studies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 19, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

May 9, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 5, 2024

Completed
Last Updated

February 12, 2025

Status Verified

February 1, 2025

Enrollment Period

4 months

First QC Date

March 11, 2024

Last Update Submit

February 10, 2025

Conditions

Keywords

blood pressure measurements

Outcome Measures

Primary Outcomes (1)

  • Difference with mean awake ambulatory systolic BP

    Difference between systolic BP measured in each study arm (average of 3 measurements) with the mean awake ambulatory systolic BP

    at enrollment (time 0)

Secondary Outcomes (1)

  • Difference with mean awake ambulatory diastolic BP

    at enrollment (time 0)

Study Arms (4)

Standardized automated office BP measurements

ACTIVE COMPARATOR

BP measured using a highly standardized procedure using a validated office-grade device on a bare arm supported at heart level.

Diagnostic Test: Mean awake ambulatory BP measurements

Sleeved arm

ACTIVE COMPARATOR

BP measured using a highly standardized procedure using a validated office-grade device over a standardized sleeve with the arm supported at heart level.

Diagnostic Test: Mean awake ambulatory BP measurements

Arm not supported

ACTIVE COMPARATOR

BP measured using a highly standardized procedure using a validated office-grade device on a bare arm resting vertically.

Diagnostic Test: Mean awake ambulatory BP measurements

Non-validated device

ACTIVE COMPARATOR

BP measured using a highly standardized procedure using a non-validated home device on a bare arm supported at heart level.

Diagnostic Test: Mean awake ambulatory BP measurements

Interventions

Results from all four arms will be compared to the mean awake ambulatory BP measured on the same arm and started immediately following completion of the testing protocol.

Arm not supportedNon-validated deviceSleeved armStandardized automated office BP measurements

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults ≥ 18 years old

You may not qualify if:

  • Upper arm size outside of cuff range of selected devices (\<22 cm or \>42 cm)
  • Permanent atrial fibrillation
  • Known severe aortic stenosis
  • Ongoing pregnancy
  • Inability or unwillingness to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital du Sacré-Coeur de Montréal

Montreal, Quebec, H4J1C5, Canada

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 11, 2024

First Posted

March 19, 2024

Study Start

May 9, 2024

Primary Completion

September 5, 2024

Study Completion

September 5, 2024

Last Updated

February 12, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Data will not be shared (pilot study)

Locations